Long-Term Effects of Low-Dose Naltrexone on Immunomodulatory Properties of Human Adipose-Derived Mesenchymal Stem Cells
Iran J Immunol
31 May 2023
https://pubmed.ncbi.nlm.nih.gov/37151015/
Paul Anderson, NMD discusses his presentation on Immune Modulation in the Age of Long-COVID and Related Illnesses.
Face Blindness & Long COVID: Prosopagnosia Is a New Symptom of Long COVID
30seconds.com
10 April 2023
https://30seconds.com/health/tip/57734/Face-Blindness-Long-COVID-Prosopagnosia-Is-a-New-Symptom-of-Long-COVID
Diagnosis and Management of a Hypersensitivity Reaction to Titanium-Containing Surgical Clips: A Case Report
Cureus
13 Feb 2023
https://pubmed.ncbi.nlm.nih.gov/36938272/
Fourteen Percent of Those Who Contracted COVID-19 Face Long-Term Challenges
Pharmacy Times
16 January 2023
https://www.pharmacytimes.com/view/fourteen-percent-of-those-who-contracted-covid-19-face-long-term-challenges
Doctor Shares Alternative Spike Protein Treatments When Go-to Options Fail
Epoch Times
04 November 2022
https://archive.ph/kwlGU#selection-347.0-347.74
Low Dose Naltrexone (LDN) Increases Endorphin Levels
RecentlyHeard
30 September 2022
https://recentlyheard.com/2022/09/30/low-dose-naltrexone-ldn-increases-endorphin-levels/
When prescribed in the low dose form, LDN can help with a multitude of different ailments and issues such as anxiety, depression, inflammation, cancers, chronic pain, immune system dysfunction, and other mental health-related issues, as well.
The LDN 3: To Purchase with discounts before 1st September 2022 Go to ldnresearchtrust.org/ldn-book-3 for full details